Overview
Spherix’s coverage of the polycystic kidney disease market leverages quarterly trackers with patient chart audits to provide insights into evolving treatment trends for ADPKD, as well as ARPKD, patients. Research covers Issues such as current treatment methods, best practices in disease tracking and imaging, and potential for new pipeline products.
Services Available
Trending market evolution
Polycystic Kidney Disease (US)
Exploring the patient journey
Polycystic Kidney Disease (US)
Gauging impact of disruptive events
Nephrology Biosimilars Today and Tomorrow (US)
Renal Pipeline Tracker
Feedback from ASN Conference 2022 (US)
Nephrologist Feedback on [Current Market Event] (ongoing based on industry updates)